Possible Legislation Regarding ESA Administration On The Horizon
This article was originally published in The Pink Sheet Daily
Executive Summary
OIG report on administration protocols for erythropoiesis-stimulating agents at dialysis facilities for renal disease patients could lay foundation for possible legislation or CMS administrative action, a staffer for Rep. Stark says.